Avidity Partners Management LP Decreases Stake in Blueprint

Avidity Partners Management LP lessened its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines accounts for approximately 2.1% of Avidity […]

Related Keywords

United States , Piper Sandler , Ariel Hurley , Stifel Nicolaus , Michael Landsittel , Blueprint Medicines Co , Jump Financial , Nasdaq , Securities Exchange Commission , Compass Wealth Management , Headlands Technologies , Citigroup , Barclays , Blueprint Medicines Corporation , Blueprint Medicines Company Profile , Associates Corp , Avidity Partners Management , Blueprint Medicines , Free Report , Partners Management , Wealth Management , Management Fondsmaeglerselskab , Get Free Report , Exchange Commission , Medicines Corporation , Visit Holdingschannel , Blueprint Medicines Daily ,